Stay updated on Brentuximab/Nivolumab Combo in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Brentuximab/Nivolumab Combo in Hodgkin Lymphoma Clinical Trial page.
Latest updates to the Brentuximab/Nivolumab Combo in Hodgkin Lymphoma Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.3.2 replaces v3.3.1 on the page, indicating a minor version update with no changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check12 days agoChange DetectedPublications section updates add clarifications that publications are provided voluntarily by the study submitter and that PubMed data is auto-filled and may not always pertain to the study; a system revision tag v3.3.1 was added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check20 days agoChange DetectedRemoved the government funding/operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check34 days agoChange DetectedThe new screenshot shows only cosmetic layout and styling updates to the study page; the study content, eligibility criteria, and locations remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check63 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference4%
- Check70 days agoChange DetectedUpgrade noted: version from v3.0.2 to v3.1.0. No other content changes detected.SummaryDifference0.1%
Stay in the know with updates to Brentuximab/Nivolumab Combo in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brentuximab/Nivolumab Combo in Hodgkin Lymphoma Clinical Trial page.